Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 660

1.

Comparison of histological and morphometrical changes underlying subchondral bone abnormalities in inflammatory and degenerative musculoskeletal disorders: a systematic review.

Loef M, van Beest S, Kroon FPB, Bloem JL, Dekkers OM, Reijnierse M, Schoones JW, Kloppenburg M.

Osteoarthritis Cartilage. 2018 May 16. pii: S1063-4584(18)31264-0. doi: 10.1016/j.joca.2018.05.007. [Epub ahead of print] Review.

PMID:
29777863
2.

[Spondyloarthritis].

Syrbe U, Baraliakos X.

Z Rheumatol. 2018 May 16. doi: 10.1007/s00393-018-0475-9. [Epub ahead of print] Review. German.

PMID:
29767341
3.

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy.

Marin J, Acosta Felquer ML, Soriano ER.

Open Access Rheumatol. 2018 May 7;10:33-41. doi: 10.2147/OARRR.S116654. eCollection 2018. Review.

4.

Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.

Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE.

Curr Rheumatol Rep. 2018 May 12;20(6):35. doi: 10.1007/s11926-018-0744-2. Review.

5.

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison.

Feld J, Chandran V, Haroon N, Inman R, Gladman D.

Nat Rev Rheumatol. 2018 May 11. doi: 10.1038/s41584-018-0006-8. [Epub ahead of print] Review.

PMID:
29752461
6.

Management of aortic injury during minimally invasive lateral lumbar interbody fusion.

Safaee MM, Zarkowsky D, Eichler CM, Pekmezci M, Clark AJ.

Eur Spine J. 2018 May 7. doi: 10.1007/s00586-018-5620-2. [Epub ahead of print] Review.

PMID:
29736802
7.

The Role of Imaging in Diagnosing Axial Spondyloarthritis.

Khmelinskii N, Regel A, Baraliakos X.

Front Med (Lausanne). 2018 Apr 17;5:106. doi: 10.3389/fmed.2018.00106. eCollection 2018. Review.

8.

[Becoming older with axial spondyloarthritis].

Kiltz U, Baraliakos X, Buehring B, Braun J.

Z Rheumatol. 2018 Apr 24. doi: 10.1007/s00393-018-0446-1. [Epub ahead of print] Review. German.

PMID:
29691686
9.

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies.

Chyuan IT, Chen JY.

Mediators Inflamm. 2018 Feb 12;2018:2403935. doi: 10.1155/2018/2403935. eCollection 2018. Review.

10.

Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.

Miao J, Zhu P.

Curr Rheumatol Rep. 2018 Apr 16;20(5):30. doi: 10.1007/s11926-018-0729-1. Review.

PMID:
29663162
11.

Relationship between diet and ankylosing spondylitis: A systematic review.

Macfarlane TV, Abbood HM, Pathan E, Gordon K, Hinz J, Macfarlane GJ.

Eur J Rheumatol. 2018 Mar;5(1):45-52. doi: 10.5152/eurjrheum.2017.16103. Epub 2017 Oct 25. Review.

12.

The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?

Kato M, Yasuda S, Atsumi T.

Rheumatol Int. 2018 Apr 5. doi: 10.1007/s00296-018-4026-0. [Epub ahead of print] Review.

PMID:
29623390
13.

Measurement properties of patient reported outcome measures for spondyloarthritis: A systematic review.

Png K, Kwan YH, Leung YY, Phang JK, Lau JQ, Lim KK, Chew EH, Low LL, Tan CS, Thumboo J, Fong W, Østbye T.

Semin Arthritis Rheum. 2018 Mar 21. pii: S0049-0172(17)30818-1. doi: 10.1016/j.semarthrit.2018.02.016. [Epub ahead of print] Review.

PMID:
29573848
14.

Dickkopf-1 in ankylosing spondylitis: Review and meta-analysis.

Wu M, Chen M, Ma Y, Yang J, Han R, Yuan Y, Hu X, Wang M, Zhang X, Xu S, Liu R, Jiang G, Xu J, Shuai Z, Zou Y, Pan G, Pan F.

Clin Chim Acta. 2018 Jun;481:177-183. doi: 10.1016/j.cca.2018.03.010. Epub 2018 Mar 12. Review.

PMID:
29544750
15.

New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Dubash S, McGonagle D, Marzo-Ortega H.

Ther Adv Chronic Dis. 2018 Mar;9(3):77-87. doi: 10.1177/2040622317743486. Epub 2017 Dec 14. Review.

16.

Resolution of traumatic bilateral vertebral artery injury.

Igarashi Y, Kanaya T, Yokobori S, Tsukamoto T, Yokota H.

Eur Spine J. 2018 Mar 1. doi: 10.1007/s00586-018-5539-7. [Epub ahead of print] Review.

PMID:
29497851
17.

Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017.

Scott FI, Lichtenstein GR.

Curr Treat Options Gastroenterol. 2018 Mar;16(1):147-164. doi: 10.1007/s11938-018-0177-z. Review.

PMID:
29492747
18.

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.

Fleisher M, Marsal J, Lee SD, Frado LE, Parian A, Korelitz BI, Feagan BG.

Dig Dis Sci. 2018 Apr;63(4):825-833. doi: 10.1007/s10620-018-4971-1. Epub 2018 Feb 26. Review.

19.

MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations 'Not everything that glisters is gold (standard)'.

Lukas C, Cyteval C, Dougados M, Weber U.

RMD Open. 2018 Jan 12;4(1):e000586. doi: 10.1136/rmdopen-2017-000586. eCollection 2018. Review.

20.

Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton.

Dubrovsky AM, Lim MJ, Lane NE.

Calcif Tissue Int. 2018 May;102(5):607-618. doi: 10.1007/s00223-018-0401-9. Epub 2018 Feb 22. Review.

PMID:
29470611

Supplemental Content

Loading ...
Support Center